mRNA |
Gemcitabine |
gCSI |
pan-cancer |
AAC |
-0.073 |
0.2 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.048 |
0.2 |
mRNA |
XMD14-99 |
GDSC1000 |
pan-cancer |
AAC |
0.045 |
0.2 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.045 |
0.2 |
mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
0.098 |
0.2 |
mRNA |
IC-87114 |
CTRPv2 |
pan-cancer |
AAC |
-0.05 |
0.2 |
mRNA |
AKT inhibitor VIII |
GDSC1000 |
pan-cancer |
AAC |
-0.046 |
0.2 |
mRNA |
R428 |
CTRPv2 |
pan-cancer |
AAC |
0.056 |
0.2 |
mRNA |
GDC-0941 |
gCSI |
pan-cancer |
AAC |
-0.077 |
0.2 |
mRNA |
CGP-60474 |
GDSC1000 |
pan-cancer |
AAC |
-0.071 |
0.2 |